Abbott Laboratories gains attention as medical devices, diabetes care, cardiovascular products, and raised guidance ...
Abbott Laboratories (NYSE:ABT) released second-quarter financial results and hosted an earnings call on Thursday. Read the ...
Abbott Laboratories' strength in Medical Devices business and the recently acquired Exact Sciences should keep driving growth ...
MarketBeat on MSN
Abbott Laboratories Q2 earnings call highlights
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott Laboratories (NYSE:ABT) reported second-quarter ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
ABT heads into Q2 earnings results with growth expected across Diagnostics, Devices and EPD, while Nutrition remains a drag.
Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Hundreds of economists urge immediate action to address AI's potential impact on the economy. In an open letter released ...
According to MarketsandMarketstm, the Point of Care Diagnostics Market is projected to grow from about USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at a CAGR of 8.8%. Browse 250 market data ...
According to MarketsandMarkets™, the Point of Care Diagnostics Market is projected to grow from about USD 20.63 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results